1. Home
  2. ASRT

as 11-15-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Founded: 1995 Country:
United States
United States
Employees: N/A City: LAKE FOREST
Market Cap: 105.8M IPO Year: 1997
Target Price: $3.19 AVG Volume (30 days): 862.2K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.72 EPS Growth: N/A
52 Week Low/High: $0.73 - $1.80 Next Earning Date: 11-11-2024
Revenue: $125,763,000 Revenue Growth: -25.77%
Revenue Growth (this year): -18.35% Revenue Growth (next year): 4.68%

ASRT Daily Stock ML Predictions

Share on Social Networks: